Longmont, Colo.-based Acertara Acoustic Laboratories announces that the company’s research and development team has been awarded U.S. patent #10,470,834 related to a device used for the transportation of diagnostic ultrasound transesophageal (TEE) probes within a medical facility environment.
Acertara CEO G. Wayne Moore commented on this achievement, stating: “This represents the 27th patent our R&D team has been awarded related to diagnostic ultrasound systems and probes. Since our engineering team first developed the modern ultrasound probe repair and testing paradigm more than 20 years ago, we have been focused on developing disruptive technologies that have a meaningful impact on both the safety of ultrasound systems and probes, as well as lowering the costs of maintaining these expensive assets.”
After all, Moore says, TEE probes are some of the most expensive probes to purchase and maintain. “Because of the nature of their clinical use and high-level disinfection/sterilization requirements after each patient use, TEE probes are very susceptible to damage from both physical trauma, as well as fluid infiltration,” he adds. “Our team focused on creating a TEE transportation device that would protect the probe from physical damage when in transport from the operating room to the hospital cleaning station and back.”
Acertara Acoustic Laboratories’ research and development team has been awarded more than 50 U.S. and international patents, according to company officials. Patented products have run the gamut from 3D ultrasound devices to comprehensive probe test devices and software algorithms.
